| Literature DB >> 35562508 |
Tanya Odisho1, Awni A Shahait2, Jared Sharza3, Abubaker A Ali4,2.
Abstract
INTRODUCTION: Minimally invasive or open Graham Patch repair remains the gold standard approach for management of perforated peptic ulcers (PPU). Herein, we report outcomes of laparoscopic technique and compare it with open approach at a community hospital.Entities:
Keywords: Laparoscopic repair; Modified Cellan-Jones; Omental patch; Open repair; Perforated peptic ulcer; Peritonitis
Year: 2022 PMID: 35562508 PMCID: PMC9105587 DOI: 10.1007/s00464-022-09306-7
Source DB: PubMed Journal: Surg Endosc ISSN: 0930-2794 Impact factor: 3.453
Preoperative patient characteristics, co-morbidities and laboratory values
| All ( | Laparoscopic ( | Open ( | ||
|---|---|---|---|---|
| Gender (male) | 23 (46.9%) | 7 (43.8%) | 16 (48.5%) | 0.755 |
| Age (year ± SD) | 52.9 ± 15.4 | 54.0 ± 12.1 | 51.8 ± 16.6 | 0.596 |
| BMI (kg/m2 ± SD) | 25.0 ± 6.1 | 23.9 ± 5.7 | 25.6 ± 6.4 | 0.371 |
| ASA ≥ III | 37 (75.5%) | 10 (62.5%) | 27 (81.8%) | 0.140 |
| Previous history of PUD | 22 (44.9%) | 5 (31.3%) | 17 (51.5%) | 0.181 |
| Antiacid use | 17 (34.7%) | 3 (18.8%) | 14 (42.4%) | 0.103 |
| History of | 2 (4.1%) | 1 (6.3%) | 1 (3.0%) | 0.593 |
| Smoking | 37 (75.5%) | 13 (81.3%) | 24 (72.7%) | 0.515 |
| Alcohol intake | 35 (71.4%) | 11 (78.6%) | 24 (72.7%) | 0.319 |
| NSAIDs use | 13 (26.5%) | 6 (37.5%) | 7 (21.2%) | 0.226 |
| Cocaine abuse | 7 (14.3%) | 3 (18.8%) | 4 (12.1%) | 0.534 |
| No co-morbidities | 12 (24.5%) | 3 (18.8%) | 9 (27.3%) | 0.241 |
| Previous abdominal surgery | 24 (49.0%) | 7 (43.8%) | 17 (51.5%) | 0.610 |
| Tachycardia | 20 (40.8%) | 3 (18.8%) | 17 (51.5%) | 0.029 |
| Hypotension | 6 (12.2%) | 0 (0%) | 6 (18.2%) | 0.069 |
| Duration of symptoms | 0.701 | |||
| ≤ 12 h | 21 (42.9%) | 8 (50.0%) | 13 (39.4%) | |
| 12–24 h | 12 (24.5%) | 4 (25.0%) | 8 (24.2%) | |
| > 24 h | 16 (34.0%) | 4 (25.0%) | 12 (36.4%) | |
| Perioperative CT scan | 39 (79.6%) | 12 (75.0%) | 27 (81.9%) | 0.016 |
| Hemoglobin (mg/dL ± SD) | 13.3 ± 3.2 | 12.4 ± 3.0 | 13.8 ± 3.3 | 0.125 |
| WBC (109 cells/L ± SD) | 11.5 ± 4.6 | 13.2 ± 4.9 | 10.6 ± 4.3 | 0.089 |
| Lactic acid (29) (mg/dL ± SD) | 6.9 ± 18.1 | 2.7 ± 1.1 | 9.0 ± 22.2 | 0.237 |
| Albumin (31) (g/dL ± SD) | 3.7 ± 0.8 | 4.0 ± 0.4 | 3.5 ± 0.9 | 0.046 |
SD standard deviation, BMI body mass index, NSAID nonsteroidal anti-inflammatory drugs, CT computed tomography, WBC white blood count
Operative and postoperative details and outcomes
| All ( | Laparoscopic ( | Open ( | ||
|---|---|---|---|---|
| Time to operating room | < 0.001 | |||
| Immediately | 19 (38.8%) | 14 (87.5%) | 5 (15.2%) | |
| Within 24 h | 29 (59.2%) | 2 (12.5%) | 27 (81.8%) | |
| Delayed | 1 (2.0%) | 0 (0%) | 1 (3.0%) | |
| Site of perforation (gastric) | 21 (42.9%) | 5 (31.3%) | 16 (48.5%) | 0.362 |
| Size of perforation | 0.615 | |||
| < 1 cm | 7 (14.6%) | 2 (12.5%) | 5 (15.6%) | |
| 1–2 cm | 35 (72.9%) | 13 (81.3%) | 22 (68.8%) | |
| > 2 cm | 6 (12.6%) | 1 (6.3%) | 5 (15.7%) | |
| Type of repair | < 0.001 | |||
| Modified Graham’s patch | 9 (18.4%) | 0 (0%) | 9 (27.3%) | |
| Graham’s patch | 15 (30.6%) | 0 (0%) | 15 (45.5%) | |
| Primary repair | 2 (4.1%) | 0 (0%) | 2 (6.1%) | |
| mCJR | 23 (46.9%) | 14 (100.0%) | 7 (21.2%) | |
| Omental patch | 40 (81.6%) | 12 (75.0%) | 28 (84.8%) | 0.391 |
| JP drain | 30 (61.2%) | 9 (56.3%) | 21 (63.6%) | 0.619 |
| EBL (mL ± SD) | 51.9 ± 152.3 | 11.8 ± 2.9 | 73.8 ± 185.5 | 0.063 |
| Operative time (min ± SD) | 96.3 ± 41.9 | 117.1 ± 35.6 | 85.6 ± 41.8 | 0.010 |
| Nasogastric tube | < 0.001 | |||
| No NGT | 1 (2.0%) | 0 (0%) | 1 (3.0%) | |
| 1–2 days | 22 (44.9%) | 14 (87.5%) | 8 (24.2%) | |
| 3–5 days | 18 (36.7%) | 2 (12.5%) | 16 (48.5%) | |
| > 5 days | 8 (16.3%) | 0 (0%) | 8 (24.2%) | |
| Oral feeding resumption | 0.002 | |||
| POD1-2 | 13 (26.5%) | 10 (62.6%) | 3 (9.1%) | |
| POD3-5 | 23 (40.7%) | 5 (31.3%) | 18 (54.5%) | |
| > POD5 | 13 (32.8%) | 1 (6.1%) | 12 (28.3%) | |
| Opioid use | < 0.001 | |||
| < 3 days | 11 (22.4%) | 9 (58.3%) | 2 (6.1%) | |
| 3–5 days | 17 (34.7%) | 6 (37.5%) | 11 (33.3%) | |
| > 5 days | 21 (42.9%) | 1 (6.3%) | 20 (60.6%) | |
| Return of bowel function | 0.002 | |||
| 1–2 days | 10 (20.4%) | 7 (43.8%) | 3 (9.1%) | |
| 3–5 days | 26 (53.1%) | 9 (58.3%) | 17 (51.5%) | |
| > 5 days | 13 (26.5%) | 0 (0%) | 13 (39.4%) | |
| Empiric | 22 (44.9%) | 13 (81.3%) | 9 (27.3%) | < 0.001 |
| Morbidity rate (≥ 1 complication) | 16 (32.7%) | 2 (12.5%) | 14 (39.4%) | 0.500 |
| In house mortality | 2 (4.1%) | 0 (0%) | 2 (6.1%) | 0.347 |
| LOS(day ± SD) | 12.2 ± 14.4 | 3.7 ± 1.6 | 16.1 ± 16.3 | < 0.001 |
| Discharge location | 0.035 | |||
| Home | 36 (73.5%) | 16 (100%) | 20 (60.6%) | |
| Inpatient rehabilitations | 7 (14.3%) | 0 (0%) | 7 (21.2%) | |
| Nursing home | 2 (4.1%) | 0 (0%) | 2 (6.1%) | |
mCJR modified Cellan-Jones repair, JP Jackson Pratt, EBL estimated blood loss, SD standard deviation, NGT nasogastric tube, POD postoperative day